DSE/CITYGENINS (DSE/CITYGENINS)

Dhaka Stock Exchange: DSE/CITYGENINS · BDT

BDT 131

-0.20 (-0.2%)· Recorded snapshot

Market cap	8.9B
Revenue (ttm)	908.1M
Net income (ttm)	305.1M
EPS (ttm)	BDT 4.47
Shares out	68.2M
P/E (trailing)	29.2x
Dividend	BDT 1.00 (0.77%)
Volume	10,190
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 908.1M
Net income (ttm): 305.1M
EPS (ttm): BDT 4.47
P/E (trailing): 29.2x
Market cap: 8.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E29.2

P25 n/aP50 n/aP75 n/a

ROE18.4

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/CITYGENINS indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

BDT

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-11-04
Employees	345
Employees change	-36
Employees growth	-9.45%
Enterprise value	BDT 7.6B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Insurance Carriers
Is primary listing	Yes
ISIN number	BD0734CGIC09
Last earnings date	2026-07-28
Last refreshed	2026-10-29
Last stock split date	2018-04-30
Last stock split type	Forward
Market cap	BDT 8.9B
Next earnings date	2026-11-04
Price	BDT 130.50
Price currency	BDT
SIC code	6300
Stock price date	2026-10-28
Symbol	dse/CITYGENINS
Website	https://www.cityinsurance.com.bd

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	16.51x
Average P/E ratio (3Y)	20.25x
Average P/E ratio (5Y)	19.18x
Earnings yield	3.42%
EV/Earnings	24.77x
EV/EBIT	15.53x
EV/EBITDA	15.28x
EV/FCF	25.89x
EV/Sales	8.32x
FCF / EV yield	3.86%
FCF yield	3.28%
Graham number	51.42451
Graham upside	-60.59%
Lynch fair value	BDT 62.41
Lynch upside	-52.18%
P/B ratio	4.96x
P/E ratio	29.2x
P/FCF ratio	30.47x
P/OCF ratio	30.17x
P/S ratio	9.8x
Price / tangible book value	4.96x
Price/EBITDA ratio	18.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	53.58%
EBITDA margin	54.08%
Effective tax rate	37.1%
FCF margin	32.15%
Gross margin	79.88%
Operating margin	53.58%
Pretax margin	53.41%
Profit margin	33.6%
Profit per employee	BDT 884,262
Revenue per employee	BDT 2.6M
ROA	12.45%
ROA (5Y)	8.3%
ROCE	23.59%
ROE	18.35%
ROE (5Y)	13.57%
ROIC	17.67%
ROIC (5Y)	13.69%
Tax / revenue	19.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	50.67%
EPS growth (Q)	119.18%
EPS growth (QoQ)	45.45%
EPS growth 10Y	13.99%
EPS growth 3Y	20.36%
EPS growth 5Y	13.83%
FCF growth	43.65%
FCF growth (Q)	-19.28%
FCF growth (QoQ)	-49.59%
FCF growth 3Y	7.15%
FCF growth 5Y	11.39%
Net income growth	51.07%
Net income growth (Q)	120.17%
Net income growth (QoQ)	45.43%
Net income growth 3Y	20.35%
Net income growth 5Y	13.97%
OCF growth	44.18%
OCF growth (Q)	-18.07%
OCF growth (QoQ)	-48.79%
OCF growth 10Y	25.2%
OCF growth 3Y	7.26%
OCF growth 5Y	9.62%
Revenue growth	4.28%
Revenue growth (Q)	10.48%
Revenue growth (QoQ)	5.95%
Revenue growth 10Y	11.53%
Revenue growth 3Y	12.97%
Revenue growth 5Y	8.99%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT -2.9M
EBIT	BDT 486.6M
EBITDA	BDT 491.1M
EPS	BDT 4.47
FCF per share	BDT 4.28
Financing cash flow	BDT -68.2M
Free cash flow	BDT 291.9M
Gross profit	BDT 725.3M
Income taxes	BDT 179.9M
Investing cash flow	BDT -2.4M
Net cash flow	BDT 224.2M
Net income	BDT 305.1M
Operating income	BDT 486.6M
Revenue	BDT 908.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BDT 26.30
Debt / equity	0
Net cash (debt)	BDT 1.3B
Net cash / market cap	15.06%
Net cash growth	20.11%
Net debt / EBITDA	-2.73
Net debt / equity	-0.75
Net debt / FCF	-4.59
Piotroski F-Score	3
Property, plant and equipment	BDT 46.7M
Shareholders' equity	BDT 1.8B
Tangible book value	BDT 1.8B
Tangible book value per share	BDT 26.29
Total assets	BDT 2.6B
Total cash	BDT 1.3B
Total debt	BDT 0
Total liabilities	BDT 840.8M
WACC	7.44%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.37
Current ratio	3.63
Net working capital	BDT 165.5M
Quick ratio	3.02
Working capital	BDT 1.5B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.26%
Dividend growth	0%
Dividend growth (3Y)	-1.61%
Dividend growth (5Y)	0%
Dividend growth years	0
Dividend payment date	2026-04-29
Dividend payment years	8
Dividend payout frequency	Annual
Dividend per share	BDT 1.00
Dividend yield	0.77%
Ex-dividend date	2026-03-05
FCF payout ratio	23.35%
Last dividend	BDT 1.00
Payout ratio	22.34%
Shareholder yield	0.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	995.81%
10Y return CAGR	30.55%
10Y total return	1,337.54%
150-day SMA	BDT 113.32
15Y price change	479.41%
15Y return CAGR	14.48%
15Y total return	660.12%
1D price change	-0.15%
1M price change	-1.29%
1M total return	-1.29%
1W price change	-0.31%
1W total return	-0.31%
1Y price change	75.17%
1Y return CAGR	77.18%
1Y total return	77.11%
20-day SMA	BDT 130.81
200-day SMA	BDT 106.38
3M price change	20.95%
3M total return	20.95%
3Y price change	158.93%
3Y return CAGR	39.83%
3Y total return	173.48%
50-day SMA	BDT 128.99
50-day SMA vs 200-day SMA	50over200
52-week high	BDT 135.00
52-week high date	2026-10-05
52-week low	BDT 70.20
52-week low date	2025-11-05
5Y price change	197.27%
5Y return CAGR	27.29%
5Y total return	234.16%
6M price change	28.83%
6M total return	28.83%
All-time high	BDT 135.00
All-time high date	2026-10-05
All-time low	BDT 5.08
All-time low date	2008-01-09
Average true range (ATR)	BDT 1.39
Average volume	34.5K
Beta (1Y)	0.06
Beta (2Y)	0.09
Beta (5Y)	0.58
Change from 52-week high	-3.33%
Change from 52-week low	85.9%
Change from all-time high	-3.33%
Change from all-time low	2,467.89%
Change from open	0%
Day's gap	-0.15%
Dollar volume	BDT 1.3M
High price	BDT 131.80
Low price	BDT 130.50
Monthly RSI	82.3
Open price	BDT 130.50
Position in 52-week range	0%
Previous close	BDT 130.70
Price vs 150-day SMA	15.16%
Price vs 20-day SMA	-0.23%
Price vs 200-day SMA	22.68%
Price vs 50-day SMA	1.17%
Relative volume	0.29
RSI	56.78
Sharpe ratio	4.09
Sharpe ratio (3Y)	1.17
Sharpe ratio (5Y)	0.83
Sortino ratio	10.06
Sortino ratio (3Y)	2.09
Sortino ratio (5Y)	1.63
Volume	10.2K
Weekly RSI	0
YTD price change	49.49%
YTD total return	51.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42.2M
Shares change (QoQ)	-0.02%
Shares change (YoY)	0.26%
Shares held by insiders	38.11%
Shares outstanding	68.2M

Deeper analysis on DSE/CITYGENINS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/CITYGENINS report

Is a complete DSE/CITYGENINS research report available?

No complete published report is available for dse/CITYGENINS (DSE/CITYGENINS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/CITYGENINS (DSE/CITYGENINS)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/CITYGENINS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/CITYGENINS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/CITYGENINS

Frequently asked questions